ND Biosciences’ publishes a new paper in collaboration with the EPFL and ADX NeuroScience describing thorough characterization of

ND Biosciences awarded a grant from The Michael J. Fox Foundation to accelerate the development of its assays

ND-BioSciences Announces partnership with The Michael J. Fox Foundation for parkinson’s research to make available unique synuclein proteoforms

ND BioSciences, a Swiss-based biotechnology company that was

ND BioSciences, the Swiss biotech co-founded by Prof. Hilal Lashuel, the director of the laboratory of molecular and chemical biology

La start-up qui veut combattre les maladies neurodégénératives par des traitements novateurs

The biotech start-up based at Biopôle is developing innovative technologies for early diagnostics and therapies

The development of disease models that recapitulate the key pathological and clinical features of neurodegenerative diseases

ND BioSciences, the Swiss biotech co-founded by Prof. Hilal Lashuel, the director of the laboratory of molecular and chemical biology

ND BioSciences, a Swiss-based biotechnology company that was

ND BioSciences, a Swiss-based biotechnology company that was